Related references
Note: Only part of the references are listed.Oncogenic Activation of NF-kappa B
Louis M. Staudt
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Life and death by death receptors
Maria Eugenia Guicciardi et al.
FASEB JOURNAL (2009)
Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation
Ikuhiko Nakase et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Dihydroartemisinin is an inhibitor of ovarian cancer cell growth
Yang Jiao et al.
ACTA PHARMACOLOGICA SINICA (2007)
Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma
Stefano Ferrari et al.
CURRENT OPINION IN ONCOLOGY (2007)
Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1α activation in C6 glioma cells
Xiao-Jia Huang et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells
Woong Nam et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2007)
Evidence for the involvement of carbon-centered radicals in the induction of apoptotic cell death by artemisinin compounds
Amy E. Mercer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Mitochondria as the target of the pro-apoptotic protein Bax
Ernine Er et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2006)
Dihydroartemisinin inhibits angiogenesis induced by multiple myeloma RPMI8226 cells under hypoxic conditions via downregulation of vascular endothelial growth factor expression and suppression of vascular endothelial growth factor secretion
Xiu-Hua Wu et al.
ANTI-CANCER DRUGS (2006)
Skip metastases in osteosarcoma:: Experience of the cooperative osteosarcoma study group
L Kager et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells
T Efferth
CURRENT DRUG TARGETS (2006)
Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane
M Jung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells
J Lee et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat
H Lai et al.
CANCER LETTERS (2006)
Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro
M Longo et al.
REPRODUCTIVE TOXICOLOGY (2006)
Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo
GL Disbrow et al.
CANCER RESEARCH (2005)
Osteosarcoma cell lines display variable individual reactions on wildtype P53 and Rb tumour-suppressor transgenes
OJC Hellwinkel et al.
JOURNAL OF GENE MEDICINE (2005)
Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate
R Dell'Eva et al.
BIOCHEMICAL PHARMACOLOGY (2004)
A medicinal chemistry perspective on artemisinin and related endoperoxides
PM O'Neill et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Characterisation of Cdc25B localisation and nuclear export during the cell cycle and in response to stress
A Lindqvist et al.
JOURNAL OF CELL SCIENCE (2004)
Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro
HH Chen et al.
PHARMACOLOGICAL RESEARCH (2003)
Regulating mammalian checkpoints through Cdc25 inactivation
M Donzelli et al.
EMBO REPORTS (2003)
Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer
M Jung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether
T Efferth et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells
NP Singh et al.
LIFE SCIENCES (2001)
Regulation of the G2/M transition by p53
WR Taylor et al.
ONCOGENE (2001)
Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells
KM Murphy et al.
CELL DEATH AND DIFFERENTIATION (2000)
Share Paper
